HOVILPRI

Serial Number 79372254
Registration 7539866
700

Registration Progress

Application Filed
Mar 23, 2023
Under Examination
Approved for Publication
Aug 6, 2024
Published for Opposition
Aug 6, 2024
Registered
Oct 22, 2024

Trademark Image

HOVILPRI

Basic Information

Serial Number
79372254
Registration Number
7539866
Filing Date
March 23, 2023
Registration Date
October 22, 2024
Published for Opposition
August 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 22, 2024
Registration
Registered
Classes
005 010 041 044

Rights Holder

AIC316 GmbH

99
Address
Friedrich-Ebert-Str. 475
42117 Wuppertal
DE

Ownership History

AIC316 GmbH

Original Applicant
99
DE

AIC316 GmbH

Owner at Publication
99
DE

AIC316 GmbH

Original Registrant
99
DE

Legal Representation

Attorney
F. William McLaughlin

USPTO Deadlines

Next Deadline
1928 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-22)
Due Date
October 22, 2030
Grace Period Ends
April 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description
Apr 12, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2025 FIMP P FINAL DISPOSITION PROCESSED
Mar 26, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jan 22, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 22, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 22, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jul 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2024 RFNT P REFUSAL PROCESSED BY IB
Dec 28, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 28, 2023 RFRR P REFUSAL PROCESSED BY MPU
Dec 20, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN
Dec 19, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 27, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Jun 23, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Antivirals; antivirals for topical use; Medicine for treatment of infectious diseases, viral infections, herpes simplex virus infections, Medicine for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Medicines for treatment of infectious diseases, viral infections, herpes simplex virus infections for human purposes, Medicines for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections for human purposes; Medicines for treatment of viral infections for veterinary purposes; Medicines for dental purposes; medicated eye lotions for medical use; medicated eye ointment for medical use; Creams for dermatological use; Dermatological-pharmaceutical products; Medicated lip creams; Medicated skin creams; Medicated skin lotions; Medicinal preparations for the treatment of infectious diseases; Medicated ointments for application to the skin for treating dermatological conditions; Medicated preparations for treating dermatological conditions; Medicated ointments for treating dermatological conditions; medicated preparations for the treatment of herpes of the lips; Ophthalmological preparations; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ophthalmological use; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical lip ointments; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations and substances for use in urology; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for skin wounds; Sulfonamides being medicines; Sulfonamide preparations; Transdermal patches for medical treatment of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical lipsalves; Antiviral drugs for treating herpes simplex virus infections; Preparations for the treatment of genital herpes; Medicinal preparations for the treatment of herpes simplex virus infections; medicinal preparations for the treatment of labial herpes; medicinal preparations for the treatment of mucosal herpes; Pharmaceutical preparations for the treatment of herpes simplex virus infections; Pharmaceutical preparations for skin lesions; Sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of tablets for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of tablets for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of solutions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of solutions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of suspensions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of suspensions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations for intra-veneous application for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations for intra-veneous application for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Antiviral drugs for treating of sexually transmittable diseases; Medicinal preparations for the treatment of sexually transmittable diseases.
Class 010
Medical devices for intra-vaginal use for treatment of infectious diseases, viral infections, herpes simplex virus infections; Medical devices for intra-vaginal use for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; medical devices for intra-vaginal application of anti-virals; medical devices for intra-vaginal application of sulfonamides
Class 041
Organization of seminars and conventions in the field of medicine; Publication of scientific information journals; publishing of online electronic publications; publishing of electronic publications; providing education courses in the field of science; Organization of seminars and conventions in the field of virology.
Class 044
Pharmaceutical consultancy services; consultancy and information services relating to medical products; providing health information; information services relating to health care; provision of health information; medical information services provided via the internet

Classification

International Classes
005 010 041 044